Abstract
Cerebrospinal fluid (CSF) immunoglobulin free light chains (FLCs) have been proposed as a quantitative and automatable alternative to oligoclonal bands (OCBs) with a potential role as predictor of Multiple Sclerosis (MS) severity. The aim of the study is to evaluate the utility of FLC determination in the initial assessment of patients with suspected MS as a diagnostic and prognostic biomarker.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
